1. Mao, Chao, Liu, Xiaoguang, Zhang, Yilei, Olszewski, Kellen, Gan, Boyi. 2021. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. In Nature, 593, 586-590. doi:10.1038/s41586-021-03539-7. https://pubmed.ncbi.nlm.nih.gov/33981038/
2. Mullen, Nicholas J, Shukla, Surendra K, Thakur, Ravi, Hollingsworth, Michael A, Singh, Pankaj K. 2024. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. In eLife, 12, . doi:10.7554/eLife.87292. https://pubmed.ncbi.nlm.nih.gov/38973593/
3. Zhu, Yifan, Jiang, Chenyu, He, Jian, Zhang, Hao, Liu, Yiwei. 2024. Cirbp suppression compromises DHODH-mediated ferroptosis defense and attenuates hypothermic cardioprotection in an aged donor transplantation model. In The Journal of clinical investigation, 134, . doi:10.1172/JCI175645. https://pubmed.ncbi.nlm.nih.gov/38690728/
4. Sykes, David B, Kfoury, Youmna S, Mercier, François E, Schreiber, Stuart L, Scadden, David T. 2016. Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia. In Cell, 167, 171-186.e15. doi:10.1016/j.cell.2016.08.057. https://pubmed.ncbi.nlm.nih.gov/27641501/
5. Yang, Kai, Fu, Li-Man, Chu, Xiao-Yang, Yin, Cheng-Hong, Guo, Qing. 2023. Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population. In Molecular genetics & genomic medicine, 11, e2186. doi:10.1002/mgg3.2186. https://pubmed.ncbi.nlm.nih.gov/37120754/
6. Dong, Shuohui, Zhang, Mingguang, Cheng, Zhiqiang, Zhang, Guangyong, Hu, Sanyuan. 2024. Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer. In Redox biology, 73, 103207. doi:10.1016/j.redox.2024.103207. https://pubmed.ncbi.nlm.nih.gov/38805974/
智鼠故事 
